<DOC>
	<DOCNO>NCT01639599</DOCNO>
	<brief_summary>Low-dose haloperidol know effective treatment postoperative nausea vomiting ( PONV ) . However , precise dose-response study complete , especially patient high risk PONV require combination therapy . This study seek identify optimal dose haloperidol could combine dexamethasone without adverse effect high-risk PONV patient receive intravenous patient-controlled anesthesia ( IV PCA ) gynecological laparoscopic surgery .</brief_summary>
	<brief_title>Optimal Haloperidol Dose Postoperative Nausea Vomiting Prevention High-risk Patients</brief_title>
	<detailed_description>Female adult three establish PONV risk factor base Apfel 's score randomise one three study group . At end anaesthesia , group H0 , H1 , H2 give intravenous ( IV ) saline , haloperidol 1 mg , haloperidol 2 mg , respectively . All patient give dexamethasone induction anaesthesia . The overall early ( 0-2 h ) late ( 2-24 h ) incidences nausea , vomit , rescue anti-emetic administration , pain , adverse effect ( cardiac arrhythmia extrapyramidal effect ) assess postoperatively . The sedation score record postanaesthesia care unit ( PACU ) .</detailed_description>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Genital Diseases , Female</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>ASA physical status I II woman Aged 20 65 year , schedule gynecologic laparoscopic surgery IV patientcontrolled analgesia ( PCA ) postoperative pain control . Known allergy intolerance study drug History cardiac arrhythmia Psychiatric illness Chronic treatment dopamine antagonist Use opioids steroid within one week surgery Use antiemetic within 24 hour study No ability use PCA device Gastrointestinal , renal , hepatic disease Insulindependent diabetes obesity body mass index &gt; 35 kg/m2 .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>non-smoker</keyword>
	<keyword>female</keyword>
	<keyword>IV PCA</keyword>
	<keyword>patient-controlled analgesia</keyword>
</DOC>